Christopher Galletta Trevi Therapeutics, Inc. (TRVI) insider trading activity

TRVI Quotes by TradingView

Christopher Galletta is of Trevi Therapeutics, Inc.. Currently has a direct ownership of 26,095 shares of TRVI, which is worth approximately $295,656. The most recent transaction as insider was on Dec 02, 2025, when has been sold 4,225 shares (Common Stock) at a price of $0.51 per share, resulting in proceeds of $2,154. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.1K
30.9% 3M change
30.9% 12M change
Total Value Held $295,656

Christopher Galletta Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2025
BUY
Exercise of conversion of derivative security
$2,154 $0.51 p/Share
4,225 Added 13.93%
26,095 Common Stock
Dec 13 2024
BUY
Exercise of conversion of derivative security
$7,650 $0.51 p/Share
15,000 Added 42.94%
19,935 Common Stock
CG

Christopher Galletta

New Haven, CT

Track Institutional and Insider Activities on TRVI

Follow Trevi Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRVI shares.

Notify only if

Insider Trading

Get notified when an Trevi Therapeutics, Inc. insider buys or sells TRVI shares.

Notify only if

News

Receive news related to Trevi Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRVI